Godshalk Welsh Capital Management, Inc. Abbott Laboratories Transaction History
Godshalk Welsh Capital Management, Inc.
- $152 Million
- Q4 2024
A detailed history of Godshalk Welsh Capital Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Godshalk Welsh Capital Management, Inc. holds 3,182 shares of ABT stock, worth $418,242. This represents 0.24% of its overall portfolio holdings.
Number of Shares
3,182
Previous 3,182
-0.0%
Holding current value
$418,242
Previous $362,000
0.83%
% of portfolio
0.24%
Previous 0.23%
Shares
14 transactions
Others Institutions Holding ABT
# of Institutions
3,275Shares Held
1.31BCall Options Held
9.63MPut Options Held
8.36M-
Vanguard Group Inc Valley Forge, PA169MShares$22.2 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$10.1 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$8.64 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$7.01 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $230B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...